BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 13678319)

  • 1. New carbocyclic lexitropsins with dinitromustard as N-terminal fragment. Inhibition of topoisomerases.
    Markowska A; Bielawska A; Bielawski K; Midura-Nowaczek K
    Acta Pol Pharm; 2003; 60(2):119-21. PubMed ID: 13678319
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aromatic analogues of DNA minor groove binders--synthesis and biological evaluation.
    Pućkowska A; Bielawski K; Bielawska A; Midura-Nowaczek K
    Eur J Med Chem; 2004 Jan; 39(1):99-105. PubMed ID: 14987838
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Carbocyclic analogues of netropsin and distamycin: DNA-binding properties and inhibition of DNA topoisomerases.
    Bartulewicz D; Bielawski K; Bielawska A
    Arch Pharm (Weinheim); 2002 Nov; 335(9):422-6. PubMed ID: 12447915
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New carbocyclic analogues of netropsin: synthesis and inhibition of topoisomerases.
    Pućkowska A; Bielawski K; Bielawska A; Rózański A
    Acta Biochim Pol; 2002; 49(1):177-83. PubMed ID: 12136938
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design, synthesis and topoisomerase II inhibition activity of 4'-demethylepipodophyllotoxin-lexitropsin conjugates.
    Gupta R; al-Said NH; Oreski B; Lown JW
    Anticancer Drug Des; 1996 Jun; 11(4):325-38. PubMed ID: 8679055
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cationic porphyrins and analogues as new DNA topoisomerase I and II inhibitors.
    Shuai L; Wang S; Zhang L; Fu B; Zhou X
    Chem Biodivers; 2009 Jun; 6(6):827-37. PubMed ID: 19551725
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Carbocyclic analogues of lexitropsin--DNA affinity and endonuclease inhibition.
    Pućkowska A; Drozdowska D; Midura-Nowaczek K
    Acta Pol Pharm; 2007; 64(2):115-9. PubMed ID: 17665860
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dual inhibition of DNA topoisomerases of Leishmania donovani by novel indolyl quinolines.
    Ray S; Sadhukhan PK; Mandal NB; Mahato SB; Majumder HK
    Biochem Biophys Res Commun; 1997 Jan; 230(1):171-5. PubMed ID: 9020039
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Understanding topoisomerase I and II in terms of QSAR.
    Verma RP
    Bioorg Med Chem; 2005 Feb; 13(4):1059-67. PubMed ID: 15670914
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibitory activities against topoisomerase I and II by polyhydroxybenzoyl amide derivatives and their structure-activity relationship.
    Abdel-Aziz M; Matsuda K; Otsuka M; Uyeda M; Okawara T; Suzuki K
    Bioorg Med Chem Lett; 2004 Apr; 14(7):1669-72. PubMed ID: 15026047
    [TBL] [Abstract][Full Text] [Related]  

  • 11. QSAR studies about cytotoxicity of benzophenazines with dual inhibition toward both topoisomerases I and II: 3D-MoRSE descriptors and statistical considerations about variable selection.
    Saíz-Urra L; González MP; Teijeira M
    Bioorg Med Chem; 2006 Nov; 14(21):7347-58. PubMed ID: 16962784
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DNA binding properties of minor groove binders and their influence on the topoisomerase II cleavage reaction.
    Bell A; Kittler L; Löber G; Zimmer C
    J Mol Recognit; 1997; 10(6):245-55. PubMed ID: 9770648
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular modelling, synthesis and antitumour activity of carbocyclic analogues of netropsin and distamycin--new carriers of alkylating elements.
    Bartulewic D; Markowska A; Wołczyński S; Dabrowska M; Rózański A
    Acta Biochim Pol; 2000; 47(1):23-35. PubMed ID: 10961675
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anthocyanidins modulate the activity of human DNA topoisomerases I and II and affect cellular DNA integrity.
    Habermeyer M; Fritz J; Barthelmes HU; Christensen MO; Larsen MK; Boege F; Marko D
    Chem Res Toxicol; 2005 Sep; 18(9):1395-404. PubMed ID: 16167831
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disulfiram is a potent in vitro inhibitor of DNA topoisomerases.
    Yakisich JS; Sidén A; Eneroth P; Cruz M
    Biochem Biophys Res Commun; 2001 Nov; 289(2):586-90. PubMed ID: 11716515
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Copper-dependent oxidative and topoisomerase II-mediated DNA cleavage by a netropsin/4'-(9-acridinylamino)methanesulfon-m-anisidide combilexin.
    Henichart JP; Waring MJ; Riou JF; Denny WA; Bailly C
    Mol Pharmacol; 1997 Mar; 51(3):448-61. PubMed ID: 9058600
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Benzothiopyranoindole-based antiproliferative agents: synthesis, cytotoxicity, nucleic acids interaction, and topoisomerases inhibition properties.
    Dalla Via L; Magno SM; Gia O; Marini AM; Da Settimo F; Salerno S; La Motta C; Simorini F; Taliani S; Lavecchia A; Di Giovanni C; Brancato G; Barone V; Novellino E
    J Med Chem; 2009 Sep; 52(17):5429-41. PubMed ID: 19725581
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DNA topoisomerases I and II in human mature sperm cells: characterization and unique properties.
    Har-Vardi I; Mali R; Breietman M; Sonin Y; Albotiano S; Levitas E; Potashnik G; Priel E
    Hum Reprod; 2007 Aug; 22(8):2183-9. PubMed ID: 17656417
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of the anticancer drug oracin on mouse liver topoisomerases I and II.
    Stuchlík S; Turna J; Miko M
    J Pharm Pharmacol; 2005 May; 57(5):657-9. PubMed ID: 15901355
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Netropsin and bis-netropsin analogs as inhibitors of the catalytic activity of mammalian DNA topoisomerase II and topoisomerase cleavable complexes.
    Beerman TA; Woynarowski JM; Sigmund RD; Gawron LS; Rao KE; Lown JW
    Biochim Biophys Acta; 1991 Aug; 1090(1):52-60. PubMed ID: 1653020
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.